Chemoinformaics analysis of 9-Methyloctadec-9-ene
| Molecular Weight | 266.513 | nRot | 14 |
| Heavy Atom Molecular Weight | 228.209 | nRig | 7 |
| Exact Molecular Weight | 266.297 | nRing | 0 |
| Solubility: LogS | -2.878 | nHRing | 0 |
| Solubility: LogP | 2.734 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 57 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 57.0681 |
| nHD | 0 | BPOL | 38.1219 |
| QED | 0.66 |
| Synth | 1.563 |
| Natural Product Likeliness | -0.06 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.002 |
| HIA | 0.003 |
| CACO-2 | -4.311 |
| MDCK | 0.0000372 |
| BBB | 0.627 |
| PPB | 0.865134 |
| VDSS | 0.887 |
| FU | 0.129474 |
| CYP1A2-inh | 0.986 |
| CYP1A2-sub | 0.27 |
| CYP2c19-inh | 0.953 |
| CYP2c19-sub | 0.156 |
| CYP2c9-inh | 0.508 |
| CYP2c9-sub | 0.18 |
| CYP2d6-inh | 0.178 |
| CYP2d6-sub | 0.179 |
| CYP3a4-inh | 0.101 |
| CYP3a4-sub | 0.371 |
| CL | 13.082 |
| T12 | 0.839 |
| hERG | 0.099 |
| Ames | 0.034 |
| ROA | 0.017 |
| SkinSen | 0.908 |
| Carcinogencity | 0.393 |
| EI | 0.968 |
| Respiratory | 0.045 |
| NR-Aromatase | 0.01 |
| Antiviral | Yes |
| Prediction | 0.594647 |